Oaktree Acquisition Corp. III Life Sciences (OACC) Income towards Parent Company (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported Income towards Parent Company of $1.4 million for Q1 2026, down 15.96% on a YoY basis from $1.7 million in Q1 2025, and down 22.07% quarter-over-quarter from $1.8 million in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Income towards Parent Company (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Income towards Parent Company for 2 years, with the latest figure at $1.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company fell 15.96% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (changed N/A YoY), and the FY2025 full-year result was $7.3 million, up 489.27% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at $1.4 million, down from $1.8 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $2.0 million in Q3 2025, with the low at $1.4 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn -
2 Centurion Acquisition 312.80 Mn 312.80 Mn -
3 Berto Acquisition 312.16 Mn 312.16 Mn -
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn -
5 Churchill Capital Corp IX 310.50 Mn 310.50 Mn -
6 WEN Acquisition 308.55 Mn 308.55 Mn -
7 Agriculture & Natural Solutions Acquisition 304.08 Mn 304.08 Mn -
8 Bold Eagle Acquisition 274.25 Mn 274.25 Mn -
9 Soulpower Acquisition 265.04 Mn 265.04 Mn -
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.39 Mn
Dec 31, 2025 1.79 Mn
Sep 30, 2025 1.97 Mn
Jun 30, 2025 1.87 Mn
Mar 31, 2025 1.66 Mn